S. W. Cho

Twenty‐four‐week clevudine therapy showed potent and sustained antiviral activity in HBeAg‐positive chronic hepatitis B†‡

Byung Chul Yoo, Ju Hyun Kim, Young–Hwa Chung et al. · Hepatology · 2007 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea‐predominant irritable bowel syndrome

K. J. Lee, Jang‐Hee Kim, S. W. Cho · Alimentary Pharmacology & Therapeutics · 2005 · 129 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Effect of virological response on post‐treatment durability of lamivudine‐induced HBeAg seroconversion

K. M. Lee, S. W. Cho, S. W. Kim et al. · Journal of Viral Hepatitis · 2002 · 72 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B

Seung Up Kim, Yeon Seok Seo, Jae Youn Cheong et al. · Alimentary Pharmacology & Therapeutics · 2010 · 50 citations · Full text

Medicine, Internal Medicine, Pathology +17

Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance

S. W. Cho, K. H. Koh, Jae Youn Cheong et al. · Journal of Viral Hepatitis · 2009 · 23 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +16